Q2 2018 CryoLife Inc Earnings Call
Conference Call CryoLife Inc
CryoLife Inc Conference call will be held on Aug 7, 2018. During the earnings conference call's session CryoLife Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact CryoLife Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
CryoLife, Inc. ("CryoLife," the "Company," "we," or "us"), incorporated in 1984 in Florida, is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. CryoLife's surgical sealants and hemostats include BioGlue® Surgical Adhesive ("BioGlue"), BioFoam® Surgical Matrix ("BioFoam"), and PerClot®, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. ("SMI"). CryoLife's CardioGenesis cardiac laser therapy product line, which includes a laser console system and single-use, fiber-optic handpieces, is used for the treatment of coronary artery disease in patients with severe angina. CryoLife is the exclusive distributor of ProCol® Vascular Bioprosthesis ("ProCol") for Hancock Jaffe Laboratories, Inc. ("Hancock Jaffe"). CryoLife marketed the Hemodialysis Reliable Outflow Graft ("HeRO® Graft") through February 3, 2016.Read more Conference Call